
### [NCIT:C4762](http://purl.obolibrary.org/obo/NCIT_C4762)
**Label:** Malignant Major Salivary Gland Neoplasm

**Subclasses:** [NCIT:C5943](http://purl.obolibrary.org/obo/NCIT_C5943) (Submandibular Gland Squamous Cell Carcinoma), [NCIT:C5900](http://purl.obolibrary.org/obo/NCIT_C5900) (Stage IV Major Salivary Gland Carcinoma without Metastasis), [NCIT:C5944](http://purl.obolibrary.org/obo/NCIT_C5944) (Malignant Submandibular Gland Mixed Tumor), [NCIT:C5945](http://purl.obolibrary.org/obo/NCIT_C5945) (Malignant Parotid Gland Mixed Tumor), [NCIT:C5946](http://purl.obolibrary.org/obo/NCIT_C5946) (Parotid Gland Undifferentiated Carcinoma), [NCIT:C5902](http://purl.obolibrary.org/obo/NCIT_C5902) (Malignant Mixed Tumor of the Major Salivary Gland), [NCIT:C5983](http://purl.obolibrary.org/obo/NCIT_C5983) (Major Salivary Gland Sarcoma), [NCIT:C3526](http://purl.obolibrary.org/obo/NCIT_C3526) (Malignant Submandibular Gland Neoplasm), [NCIT:C3525](http://purl.obolibrary.org/obo/NCIT_C3525) (Malignant Parotid Gland Neoplasm), [NCIT:C5940](http://purl.obolibrary.org/obo/NCIT_C5940) (Submandibular Gland Adenocarcinoma), [NCIT:C5941](http://purl.obolibrary.org/obo/NCIT_C5941) (Parotid Gland Adenocarcinoma), [NCIT:C5942](http://purl.obolibrary.org/obo/NCIT_C5942) (Parotid Gland Squamous Cell Carcinoma), [NCIT:C5981](http://purl.obolibrary.org/obo/NCIT_C5981) (Major Salivary Gland Non-Hodgkin Lymphoma), [NCIT:C8397](http://purl.obolibrary.org/obo/NCIT_C8397) (Sublingual Gland Carcinoma), [NCIT:C8396](http://purl.obolibrary.org/obo/NCIT_C8396) (Submandibular Gland Carcinoma), [NCIT:C6791](http://purl.obolibrary.org/obo/NCIT_C6791) (Parotid Gland Carcinoma), [NCIT:C132779](http://purl.obolibrary.org/obo/NCIT_C132779) (Major Salivary Gland Cancer by AJCC v8 Stage), [NCIT:C5907](http://purl.obolibrary.org/obo/NCIT_C5907) (Major Salivary Gland Carcinoma), [NCIT:C132778](http://purl.obolibrary.org/obo/NCIT_C132778) (Major Salivary Gland Cancer by AJCC v7 Stage), [NCIT:C3527](http://purl.obolibrary.org/obo/NCIT_C3527) (Malignant Sublingual Gland Neoplasm), [NCIT:C5947](http://purl.obolibrary.org/obo/NCIT_C5947) (Submandibular Gland Undifferentiated Carcinoma), [NCIT:C5903](http://purl.obolibrary.org/obo/NCIT_C5903) (Major Salivary Gland Adenocarcinoma), [NCIT:C5905](http://purl.obolibrary.org/obo/NCIT_C5905) (Major Salivary Gland Adenoid Cystic Carcinoma), [NCIT:C35832](http://purl.obolibrary.org/obo/NCIT_C35832) (Parotid Gland Carcinosarcoma), [NCIT:C5906](http://purl.obolibrary.org/obo/NCIT_C5906) (Major Salivary Gland Mucoepidermoid Carcinoma), [NCIT:C5899](http://purl.obolibrary.org/obo/NCIT_C5899) (Stage IV Major Salivary Gland Carcinoma with Metastasis), [NCIT:C5977](http://purl.obolibrary.org/obo/NCIT_C5977) (Submandibular Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C132783](http://purl.obolibrary.org/obo/NCIT_C132783) (Stage 0 Major Salivary Gland Cancer AJCC v8), [NCIT:C5935](http://purl.obolibrary.org/obo/NCIT_C5935) (Submandibular Gland Adenoid Cystic Carcinoma), [NCIT:C132781](http://purl.obolibrary.org/obo/NCIT_C132781) (Stage I Major Salivary Gland Cancer AJCC v8), [NCIT:C5895](http://purl.obolibrary.org/obo/NCIT_C5895) (Stage I Major Salivary Gland Cancer AJCC v7), [NCIT:C132786](http://purl.obolibrary.org/obo/NCIT_C132786) (Stage III Major Salivary Gland Cancer AJCC v8), [NCIT:C132787](http://purl.obolibrary.org/obo/NCIT_C132787) (Stage IV Major Salivary Gland Cancer AJCC v8), [NCIT:C5896](http://purl.obolibrary.org/obo/NCIT_C5896) (Stage II Major Salivary Gland Cancer AJCC v7), [NCIT:C5951](http://purl.obolibrary.org/obo/NCIT_C5951) (Parotid Gland Non-Hodgkin Lymphoma), [NCIT:C5952](http://purl.obolibrary.org/obo/NCIT_C5952) (Parotid Gland Kaposi Sarcoma), [NCIT:C5897](http://purl.obolibrary.org/obo/NCIT_C5897) (Stage III Major Salivary Gland Cancer AJCC v7), [NCIT:C5974](http://purl.obolibrary.org/obo/NCIT_C5974) (Parotid Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C132785](http://purl.obolibrary.org/obo/NCIT_C132785) (Stage II Major Salivary Gland Cancer AJCC v8), [NCIT:C5898](http://purl.obolibrary.org/obo/NCIT_C5898) (Stage IV Major Salivary Gland Cancer AJCC v7), [NCIT:C5975](http://purl.obolibrary.org/obo/NCIT_C5975) (Major Salivary Gland Carcinoma ex Pleomorphic Adenoma), [NCIT:C5958](http://purl.obolibrary.org/obo/NCIT_C5958) (Sublingual Gland Adenocarcinoma), [NCIT:C5937](http://purl.obolibrary.org/obo/NCIT_C5937) (Parotid Gland Adenoid Cystic Carcinoma), [NCIT:C5938](http://purl.obolibrary.org/obo/NCIT_C5938) (Parotid Gland Mucoepidermoid Carcinoma), [NCIT:C5939](http://purl.obolibrary.org/obo/NCIT_C5939) (Submandibular Gland Mucoepidermoid Carcinoma), 

**Class expressions from DL-Learner:**

- Thing 51.13%
- [UBERON:0001829](http://purl.obolibrary.org/obo/UBERON_0001829) (major salivary gland) 50.00%
- [UBERON:0002530](http://purl.obolibrary.org/obo/UBERON_0002530) (gland) 32.14%
- [UBERON:0015212](http://purl.obolibrary.org/obo/UBERON_0015212) (lateral structure) 31.74%
- [UBERON:0000062](http://purl.obolibrary.org/obo/UBERON_0000062) (organ) 28.79%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.24%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.37%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 26.73%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 26.67%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 26.62%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 26.52%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 26.52%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 26.42%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 26.42%


